Management of Chronic Active Epilepsy in Adults

The Treatment of Epilepsy: Third Edition

Volumn , Issue , 2009, Pages 153-162

  Shorvon, Simon D ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Chronic active epilepsy management in adults; Concomitant medication; Counselling and information provision; Drug choice as baseline regime; Folic acid supplementation; Intractable (refractory) epilepsy and drug resistance; Maternal epilepsy; Menstruation and catamenial epilepsy; Poor compliance for poor seizure control

Indexed keywords

EID: 84883788862     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444316667.ch11     Document Type: Chapter

References (30)

1. Aldren Turner W. Epilepsy - A Study of the Idiopathic Disease. London:Macmillan and Co., Limited, 1907.
2. Shorvon SD. The temporal aspects of prognosis in epilepsy. J Neurol Neurosurg Psychiatry 1984; 47: 1157-1165.
3. Shorvon SD, Sander JWAS. Temporal patterns of remission and relapse of seizures in patients with epilepsy. In: Schmidt D, Morselli PL, eds. Intractable Epilepsy: Experimental and Clinical Aspects. New York:Raven Press, 1986: 13-24.
4. Shih T, Lowenstein D. Pharmacoresistant epilepsy: if at first you don't succeed. Ann Neurol 2007; 62: 311-313.
5. Shorvon S. The treatment of chronic epilepsy: a review of recent studies of clinical efficacy and side-effects. Curr Opin Neurol 2007; 20:159-163.
6. Shorvon S, Luciano AL. Prognosis of chronic and newly diagnosed epilepsy:revisiting temporal aspects. Curr Opin Neurol 2007; 20:208-212.
7. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007; 62:375-381.
8. Kinirons P, McCarthy M, Doherty CP, Delanty N. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam. Seizure 2006; 15: 387-392.
9. Callaghan BC, Anand K, Hesdorffer D, Hauser WA, French JA. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007; 62: 382-389.
10. French JA. Refractory epilepsy: clinical overview. Epilepsia 2007; 48(Suppl. 1): 3-7.
11. French JA. Refractory epilepsy: one size does not fit all. Epilepsy Curr 2006; 6: 177-180.
12. Perucca E, Dulac O, Shorvon S, Tomson T. Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation. CNS Drugs 2001; 15: 609-621.
13. Berg AT, Langfitt J, Shinnar S, et al. How long does it take for partial epilepsy to become intractable? Neurology 2003; 60: 186-190.
14. Chadwick D, Smith D. The misdiagnosis of epilepsy. BMJ 2002; 324:495-496.
15. So EL. Role of neuroimaging in the management of seizure disorders. Mayo Clin Proc 2002; 77: 1251-1264.
16. Eriksson SH, Thom M, Bartlett PA, et al. Propeller MRI visualizes detailed pathology of hippocampal sclerosis. Epilepsia 2008; 49:33-39.
17. Perucca E, Beghi E, Dulac O, Shorvon S, Tomson T. Assessing risk to benefit ratio in antiepileptic drug therapy. Epilepsy Res 2000; 41:107-139.
18. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy:general features and interactions between antiepileptic drugs. Lancet Neurol 2003; 2: 347-356.
19. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 2006; 61: 246-255.
20. Moran NF, Poole K, Bell G, et al. Epilepsy in the United Kingdom:seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure 2004; 13: 425-433.
21. Tellez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S. Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain 2007; 130: 334-345.
22. Bien CG, Schulze-Bonhage A, Soeder BM, Schramm J, Elger CE, Tiemeier H. Assessment of the long-term effects of epilepsy surgery with three different reference groups. Epilepsia 2006; 47: 1865-1869.
23. McIntosh AM, Kalnins RM, Mitchell LA, Fabinyi GC, Briellmann RS, Berkovic SF. Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain 2004; 127: 2018-2030.
24. Perucca E. Age-related changes in pharmacokinetics: predictability and assessment methods. Int Rev Neurobiol 2007; 81: 183-199.
25. Levy RH, Collins C. Risk and predictability of drug interactions in the elderly. Int Rev Neurobiol 2007; 81: 235-251.
26. Lackner TE, Cloyd JC, Thomas LW, Leppik IE. Antiepileptic drug use in nursing home residents: effect of age, gender, and co-medication on patterns of use. Epilepsia 1998; 39: 1083-1087.
27. Shorvon SD, Tallis RC, Wallace HK. Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice. J Neurol Neurosurg Psychiatry 2002; 72: 114-115.
28. Löfgren E, Mikkonen K, Tolonen U, et al. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication. Epilepsy Behav 2007; 10: 77-83.
29. O'Brien MD, Guillebaud J. Contraception for women with epilepsy. Epilepsia 2006; 47: 1419-1422.
30. Shorvon SD. Handbook of Epilepsy Treatment. Oxford: Blackwell, 2005.